Showing results (591-600 of 3,353) with videos related to

Sort By:
Pageof 336
Current Pharmaceutical Design|May 18, 2012
Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancerBradley J Monk, Heather Dalton, Ivor Benjamin, et al.
Biochimica Et Biophysica Acta|April 28, 1994
Multiple signalling pathways in the C5a-induced expression of adhesion receptor Mac-1P N Monk, M D Barker, L J Partridge
The Journal of Laryngology and Otology|March 29, 2001
How common is hearing impairment in osteogenesis imperfecta?C R Paterson, E A Monk, S J McAllion
International Journal of Pharmaceutics|April 25, 2003
Binding of primaquine to epidermal membranes and keratinC M Heard, B V Monk, A J Modley
British Journal of Anaesthesia|May 1, 1984
Effect of nitrous oxide on halothane-induced hepatotoxicity in hypoxic, enzyme-induced ratsJ A Ross, S J Monk, S W Duffy
Anesthesiology|November 1, 1983
No effect of hyperbaric oxygen on methionine synthetase activity in ratsN M Sharer, S J Monk, J F Nunn
Anesthesiology|December 25, 2007
Type and severity of cognitive decline in older adults after noncardiac surgeryCatherine C Price, Cynthia W Garvan, Terri G Monk
Annals of the New York Academy of Sciences|December 24, 1997
The plasma membrane H(+)-ATPase of fungi. A candidate drug target?D S Perlin, D Seto-Young, B C Monk
Aviation, Space, and Environmental Medicine|July 22, 2006
Using daily 30-min phase advances to achieve a 6-hour advance: circadian rhythm, sleep, and alertnessTimothy H Monk, Daniel J Buysse, Bart D Billy
Pageof 336